TTK drug discovery program presented at Protein Kinases conference in Berlin

Guido Zaman and Suzanne van Gerwen will attend the 10^th “Protein Kinases in Drug Discovery” conference, that will be held in Berlin on May 7^th and 8^th.

On Friday, May 8^th, Guido Zaman will present on the NTRC’s TTK (Mps1) kinase inhibitor program.

Title of presentation: Selective TTK inhibitors with long target residence time and potent anti-tumor activity

Time: 8:45 a.m.